SCHEMBL21401005

SCHEMBL21401005

Cc1ncccc1CC(C)N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.41
TAAR1 Q96RJ0 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
MAOA P21397 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
P2RX7 Q99572 1/20 0.40
SOS2 Q07890 1/20 0.39
ADRB1 P08588 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR1E P28566 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2084548 0.84 GABRA1 (0.47) P2RX7
SCHEMBL23075001 0.81 SLC6A2 (0.41) SLC6A2TAAR1SLC6A4SLC6A3MAOA
SCHEMBL9519949 0.79 PTAFR (0.42) SLC6A2SLC6A4SLC6A3MAOAP2RX7
SCHEMBL9519911 0.79 PTAFR (0.42) SLC6A2SLC6A4SLC6A3MAOAP2RX7
SCHEMBL9519919 0.79 PTAFR (0.42) SLC6A2SLC6A4SLC6A3MAOAP2RX7
SCHEMBL24741410 0.78 P2RX7 (0.37) P2RX7
SCHEMBL27359227 0.78 SLC6A2 (0.38) SLC6A2TAAR1SLC6A4SLC6A3MAOA
Water SCHEMBL9522425 0.78 PTAFR (0.41) SLC6A2SLC6A4SLC6A3MAOAP2RX7
SCHEMBL5802969 0.75
SCHEMBL261850 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019183364-A1 PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed